[Clinical significance of the clearance tests for examination of the renal function with special reference to the problems of differential diagnosis. II. Essential hypertension, malignant sclerosis, cardiac insufficiency, polycythemia and multiple myeloma].
D003937:Diagnosis, Differential; D000075222:Essential Hypertension; D006333:Heart Failure / Q000175:diagnosis*; D006801:Humans; D006973:Hypertension / Q000175:diagnosis*; D007677:Kidney Function Tests; D009101:Multiple Myeloma / Q000175:diagnosis*; D010950:Plasma Cells; D011086:Polycythemia / Q000175:diagnosis*; D012598:Sclerosis
CONGESTIVE HEART FAILURE/differential diagnosis; HYPERTENSION/differential diagnosis; KIDNEY FUNCTION TESTS; MYELOMA, PLASMA CELL/differential diagnosis; POLYCYTHEMIA/differential diagnosis
Die Bedeutung der Clearancemethodik zur Prüfung der Nierenfunktion für die Klinik unter besonderer Berücksichtigung differentialdiagnostischer Fragestellungen. II. Essentielle Hypertonie und maligne Sklerose. Herzinsuffizienz, Polyzythämie, multiple Myelome.